Filed 21d ago· May 13, 2026
41 days to disclose
Byron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–10 of 10
Filed 21d ago· May 13, 2026
41 days to discloseByron Donalds
RHouseFlorida-19
↑bought
Eli Lilly
LLY
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 2, 2026
SP Eli Lilly and Company
Filed 1.0y ago· May 24, 2025
44 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+10.1% vs S&P 500
Trade dateApr 10, 2025
Common Stock
Filed 1.0y ago· May 24, 2025
44 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+10.1% vs S&P 500
Trade dateApr 10, 2025
Common Stock
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Novo Nordisk
NVO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Novo Nordisk
NVO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.3y ago· Feb 10, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Merck
MRK
$1K-$15K
+5.2% vs S&P 500
Trade dateJan 16, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Merck
MRK
$1K-$15K
+5.2% vs S&P 500
Trade dateJan 16, 2025
Stock
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2026 21d ago | Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY SP Eli Lilly and Company | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 24, 2025 1.0y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Apr 10, 2025 44 days to disclose | Flat·+0.0% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 24, 2025 1.0y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Apr 10, 2025 44 days to disclose | Flat·+0.0% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Novo Nordisk NVO | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Novo Nordisk NVO | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Merck MRK Stock | Jan 16, 2025 25 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Merck MRK Stock | Jan 16, 2025 25 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |